Primary study · included by 1 review

Langerhans' cell histiocytosis: paediatric head and neck study.

al-Ammar 1999 · al-Ammar A Y, Tewfik T L, Bond M, et al. · The Journal of otolaryngology · 1999

Included by

Prevalence of oral lesions in Langerhans cell histiocytosis: a systematic review and meta-analysis.
Non-Cochrane · prognostic · 2026 · cited as al-Ammar 1999 · Table 4; Reference list
Outcome this study informsPooled effectEvidenceCertainty
Prevalence of oral manifestations (oral mucosa or jaw bone lesions)
Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified)
Proportion 0.097 [0.076, 0.119]11 studies · 1806 participantsGRADE not reported
Prevalence of oral manifestations (oral mucosa or jaw bone lesions)
Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified)
Proportion 0.205 [0.144, 0.267]16 studies · 2052 participantsLow
Prevalence of oral manifestations
Oral manifestations (oral mucosa and jaw bone lesions) vs Not applicable · At diagnosis
Prevalence (%) 14.86 [11.80, 18.58]16 studies · 2052 participantsLow
Prevalence of oral manifestations (oral mucosa or jaw bone lesions)
Oral manifestations of LCH (oral mucosa and jaw bone lesions) vs Not applicable (single-arm prevalence) · At diagnosis (not specified)
Proportion 0.105711 studies · 1806 participantsGRADE not reported

1 including review in total.